TickerFactsScreenerDevelopers

Pacira BioSciences, Inc. (PCRX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2009: $12.30M2010: $12.28M2011: $16.74M2012: $32.14M2013: $54.77M2014: $77.44M2015: $71.84M2016: $110.10M2017: $87.92M2018: $86.84M2019: $106.71M2020: $117.33M2021: $140.25M2022: $199.29M2023: $184.67M2024: $170.43M2025: $149.75M$149.75M
2009Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$149.75M-12.1%
2024$170.43M-7.7%
2023$184.67M-7.3%
2022$199.29M+42.1%
2021$140.25M+19.5%
2020$117.33M+9.9%
2019$106.71M+22.9%
2018$86.84M-1.2%
2017$87.92M-20.2%
2016$110.10M+53.3%
2015$71.84M-7.2%
2014$77.44M+41.4%
2013$54.77M+70.4%
2012$32.14M+92.0%
2011$16.74M+36.4%
2010$12.28M-0.2%
2009$12.30M—